253 related articles for article (PubMed ID: 33832398)
1. Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management.
Savla SR; Prabhavalkar KS; Bhatt LK
Expert Rev Anti Infect Ther; 2021 Nov; 19(11):1397-1413. PubMed ID: 33832398
[TBL] [Abstract][Full Text] [Related]
2. The Cross-Talk between Thrombosis and Inflammatory Storm in Acute and Long-COVID-19: Therapeutic Targets and Clinical Cases.
Acanfora D; Acanfora C; Ciccone MM; Scicchitano P; Bortone AS; Uguccioni M; Casucci G
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696334
[TBL] [Abstract][Full Text] [Related]
3. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
4. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
6. Complement activation and coagulopathy - an ominous duo in COVID19.
Tomo S; Kumar KP; Roy D; Sankanagoudar S; Purohit P; Yadav D; Banerjee M; Sharma P; Misra S
Expert Rev Hematol; 2021 Feb; 14(2):155-173. PubMed ID: 33480807
[TBL] [Abstract][Full Text] [Related]
7. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
Xu K; Wei Y; Giunta S; Zhou M; Xia S
Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 coagulopathy: is it disseminated intravascular coagulation?
Levi M; Iba T
Intern Emerg Med; 2021 Mar; 16(2):309-312. PubMed ID: 33368021
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated coagulopathy and disseminated intravascular coagulation.
Asakura H; Ogawa H
Int J Hematol; 2021 Jan; 113(1):45-57. PubMed ID: 33161508
[TBL] [Abstract][Full Text] [Related]
10. Coagulation Dysfunction.
Fei Y; Tang N; Liu H; Cao W
Arch Pathol Lab Med; 2020 Oct; 144(10):1223-1229. PubMed ID: 32551814
[TBL] [Abstract][Full Text] [Related]
11. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism.
Ahmad F; Kannan M; Ansari AW
Cytokine Growth Factor Rev; 2022 Feb; 63():58-68. PubMed ID: 34750061
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Associated Hemophagocytic Lymphohistiocytosis and Coagulopathy: Targeting the Duumvirate.
Bhattacharjee S; Banerjee M; Pal R
Indian Pediatr; 2020 Sep; 57(9):827-833. PubMed ID: 32583809
[TBL] [Abstract][Full Text] [Related]
13. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
[TBL] [Abstract][Full Text] [Related]
14. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy.
Mitchell WB; Davila J; Keenan J; Jackson J; Tal A; Morrone KA; Silver EJ; O'Brien S; Manwani D
Pediatr Blood Cancer; 2021 Jul; 68(7):e28975. PubMed ID: 33661561
[TBL] [Abstract][Full Text] [Related]
15. COVID-19, coagulopathy and venous thromboembolism: more questions than answers.
Marietta M; Coluccio V; Luppi M
Intern Emerg Med; 2020 Nov; 15(8):1375-1387. PubMed ID: 32653981
[TBL] [Abstract][Full Text] [Related]
16. Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines.
Abdel-Bakky MS; Amin E; Ewees MG; Mahmoud NI; Mohammed HA; Altowayan WM; Abdellatif AAH
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215822
[TBL] [Abstract][Full Text] [Related]
17. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
Shi C; Wang C; Wang H; Yang C; Cai F; Zeng F; Cheng F; Liu Y; Zhou T; Deng B; Vlodavsky I; Li JP; Zhang Y
Clin Transl Sci; 2020 Nov; 13(6):1087-1095. PubMed ID: 32881340
[TBL] [Abstract][Full Text] [Related]
18. [Peculiarities of blood coagulation disorders in patients with COVID-19].
Evtugina NG; Sannikova SS; Peshkova AD; Safiullina SI; Andrianova IA; Tarasova GR; Khabirova AI; Rumyantsev AG; Ataullakhanov FI; Litvinov RI
Ter Arkh; 2021 Nov; 93(11):1255-1263. PubMed ID: 36286646
[TBL] [Abstract][Full Text] [Related]
19. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
AlNafea HM; Korish AA
Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
[TBL] [Abstract][Full Text] [Related]
20. Understanding the andromeda strain - The role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness.
Mir N; D'Amico A; Dasher J; Tolwani A; Valentine V
Blood Rev; 2021 Jan; 45():100731. PubMed ID: 32829961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
